Aptar Pharma and BD Announce Deal to Bring New Auto-Injector to Market

-

French drug delivery solutions provider Aptar Pharma announced an exclusive deal with Becton, Dickinson and Company (BD) to develop and commercialize a novel auto-injector based on Aptar’s two-step device and BD’s prefillable syringes.

BD is a leading manufacturer of syringes including the BD Hypak prefillable syringe. Aptar currently markets Pro-Ject™, a relatively small, lightweight disposable auto-injector used for delivery of biologics and other drugs.

Click to visit sponsor

Aptar’s auto-injector was specifically designed around BD’s stable of prefilled syringes and the company claims to hold a number of patents on the design. Under the agreement, BD – a global medical technology firm – will commercialize the product.

Here is Aptar’s video showing the design features and administration of Pro-Ject:

As the device is being developed to deliver a variety of drugs across a range of applications, the economies of scale could potentially result in a lower cost alternative for epinephrine delivery.

Print or share this article
Click to visit sponsor
Dave Bloom
Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of SnackSafely.com.

Find Allergy-Friendly Products

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.